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Abstract
Introduction: The aim of the study was to evaluate the effect of a single freeze/thaw cycle on HbA1c concentrations measured by commercially 
available HPLC method.
Materials and methods: Study included 128 whole blood samples collected from diabetic patients (N = 60) and healthy volunteers (N = 68). 
HbA1c concentrations were measured in fresh blood samples. Then samples were frozen at - 80 °C for up to 12 weeks. HbA1c was assayed by ion-
exchange HPLC method on Bio-Rad D-10® analyzer. Variables were compared using Wilcoxon and ANOVA Kruskal-Wallis tests. Bias between HbA1c 
measured in fresh and frozen samples was calculated. The comparability of HbA1c concentrations was assessed by Bland-Altman plot.
Results: Median (IQR) HbA1c concentration was 45.3 (36.6–61.2) mmol/mol for fresh and 45.3 (36.6–60.6) mmol/mol for frozen/thawed samples. 
No significant difference in HbA1c concentrations was found comparing fresh and frozen/thawed samples (P = 0.070) in the whole group, as well 
as in healthy and diabetic subjects. The median calculated bias between fresh and frozen/thawed samples was 0% in whole group and healthy 
subjects, and 1.19% in diabetic patients. No significant difference was found between the biases according to baseline HbA1c values (P = 0.150). 
The Bland-Altman plot analysis showed a positive bias of 0.4% (95% CI: - 2.8 - 3.7%), which indicates high compliance between HbA1c values and no 
relevant influence of sample freezing on clinical significance of HbA1c measurement.
Conclusions: Storage for up to 12 weeks at – 80 °C with a single freeze/thaw cycle does not affect HbA1c concentrations measured with HPLC met-
hod on Bio-Rad D-10® analyzer.
Key words: glycated haemoglobin; diabetes; sample storage; high performance liquid chromatography; preanalytical phase
Received: January 05, 2016 Accepted: July 29, 2016
The influence of sample freezing at – 80 °C for 2–12 weeks on glycated 
haemoglobin (HbA1c) concentration assayed by HPLC method on Bio-Rad D-10® 
auto analyzer
Katarzyna Bergmann*, Grazyna Sypniewska




Glycated haemoglobin (HbA1c) is a product of the 
non-enzymatic binding of glucose to N-terminal 
valine residues of haemoglobin’s β chains. It is 
considered a “gold standard” for monitoring dia-
betes, however current guidelines of the American 
Diabetes Association (ADA) recommend its use as 
a diagnostic tool for diabetes (1). HbA1c concentra-
tion is strongly correlated with the development 
of long-term complications (micro- and macroan-
giopathy) in both Type 1 and Type 2 diabetes (2, 3).
Changes in the structure and chemical-physical 
properties of haemoglobin have become the start-
ing point for the development of various methods 
for its quantification. Many in vitro diagnostic 
manufacturers developed automatic analyzers 
based on enzymatic, immunological and separa-
tion methods for HbA1c assay. According to the 
standardization programme of the International 
Federation of Clinical Chemistry and Laboratory 
Medicine (IFCC), determination of HbA1c concen-
tration should be performed using high perfor-
mance liquid chromatography (HPLC) combined 
with capillary electrophoresis or mass-spectrome-
try (4). Autoanalyzers and methods used in clinical 
practice are obliged to obtain IFCC certification.
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Glycated haemoglobin concentration is stable in 
blood during short-term storage, which is its main 
advantage over glucose (5). Usually, it is measured 
in fresh samples immediately after blood collec-
tion or in samples stored at 4 °C up to 1–2 weeks. 
Bio-Rad D-10® Hemoglobin A1c Program (Bio-Rad 
Laboratories, CA, USA) is based on ion-exchange 
HPLC method which is certified by IFCC. According 
to the manufacturer, whole blood samples are sta-
ble up to 7 days when stored at 2–8 °C or 3 days at 
room temperature (15–30 °C). Sample freezing is 
not recommended (6).
Several studies evaluated repeatability of HbA1c 
concentration on different instruments after freez-
ing the blood samples which might be useful if 
prolonged storage is required (i.e. for research or 
evaluation of new methods). For prolonged stor-
age (several months or years) recommended stor-
age temperatures are -70 °C or lower (7-9). HbA1c 
concentration is stable at 4 °C usually for 2–3 
weeks, while at room temperature relevant chang-
es in HbA1c concentration are observed within 1–3 
days (8, 9). 
The aim of this study was to evaluate the effect of 
a 2–12 weeks storage period and single freeze/
thaw cycle on HbA1c concentrations measured by 
HPLC on Bio-Rad D-10® autoanalyzer in clinically 
healthy and diabetic individuals. Most studies 
evaluating the influence of sample storage on 
HbA1c concentration were performed using very 
small numbers of analysed samples. For example, 
in studies mentioned above only 3 and 5 whole 
blood samples were analyzed, which can consid-
erably limit their clinical importance (8, 9). Moreo-
ver, many studies do not distinguish results ob-
tained in healthy and diabetic subjects. In this 
study, we made an attempt to compare indicators 
of the analytical quality and recommended bias 




This applied research included 128 whole blood 
samples collected from 60 Caucasian diabetic pa-
tients (median 62 (29–81) years) and 68 Caucasian 
healthy volunteers (median 41 (18–72) years). Sub-
jects were selected based on questionnaire con-
cerning medical history and medical examination 
performed in the Department of Laboratory Medi-
cine at Nicolaus Copernicus University Collegium 
Medicum in Bydgoszcz, Poland. The diabetic 
group consisted of patients with diagnosed Type 1 
or Type 2 diabetes. The control group consisted of 
apparently healthy, non-obese subjects with nor-
mal fasting plasma glucose (3.3–5.5 mmol/L) and 
without chronic diseases in medical history (com-
prising diabetes, impaired fasting glucose or im-
paired glucose tolerance, dyslipidemia, autoim-
mune and chronic infectious diseases, cardiovas-
cular disease – previously diagnosed hyperten-
sion, atherosclerosis, coronary heart disease, myo-
cardial infarction, stroke, peripheral artery disease, 
venous thrombosis).
Written informed consent from each participant 
was obtained and the study was approved by the 
Bioethics Committee at Nicolaus Copernicus Uni-
versity Collegium Medicum in Bydgoszcz, Poland.
Blood sampling
From each subject, one sample of fasting venous 
blood was drawn in the morning (7.00–9.00 am) 
using sterile 2.0 mL plastic tubes Vacutainer® with 
potassium - EDTA (cat. no. 367841; Becton Dickin-
son, NJ, USA). Samples were delivered to the labo-
ratory and HbA1c concentrations were measured 
immediately after collection in fresh blood sam-
ples. Several samples (approximately 16–18) that 
could not be tested immediately after collection 
(for example, blood was drawn on Sunday) were 
stored at 2–8 °C for no longer than 24 hours. Sam-
ples were then transferred into sterile, tightly 
closed polypropylen tubes (cat. no. 20-1203-1; 
Medlab-Products, Raszyn, Poland) suitable for 
freezing up to –90 °C to avoid peptide degrada-
tion and potential interference with the material 
of blood collection tubes, and frozen at –80 °C. 
Samples were stored for up to 12 weeks. 
Samples were divided according to the three stor-
age time intervals: 2–5 weeks (N = 40), 6–9 weeks 
(N = 45) and 10-12 weeks (N = 43). This division was 
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used to obtain comparable size groups and similar 
number of diabetic and healthy subjects matched 
by age, sex and baseline HbA1c concentration in 
each storage time interval.
Samples were thawed in the refrigerator, brought 
to room temperature and thoroughly mixed on a 
roller mixer (MX-T6-S, Medlab-Products, Raszyn, 
Poland) prior to the assay.
Methods
HbA1c was assayed by ion-exchange high perfor-
mance liquid chromatography (HPLC) method cer-
tified by National Glycohemoglobin Standardiza-
tion Program (NGSP) and IFCC on Bio-Rad D-10® 
(Bio-Rad Laboratories, CA, USA) autoanalyzer with 
reportable range 18 - 179 mmol/mol (3.8–18.5%) 
and total precision CV = 1.16%. The instrument au-
tomatically dilutes whole blood samples and in-
jects them into the analytical cartridge. In the next 
step, different fractions of haemoglobin are sepa-
rated using buffer gradient of increasing ionic 
strength. Each type of haemoglobin is measured 
by spectrophotometry at 415 nm.
Results were obtained in NGSP units (%). To con-
vert results to IFCC units (mmol/mol), the follow-
ing equation was used: IFCC = (10.93 x NGSP) - 
23.50 (4).
The quality control of this assay was performed 
every day during the study using Bio-Rad 
Lyphochek® Diabetes Control with the following 
reference values: level 1 (low) 5.4%–42.1 mmol/
mol) and level 2 (high) 9.6%; ranged 8.4–10.8% 
(81.4 mmol/mol; ranged 68.3–94.5 mmol/mol). 
The intra-assay variation calculated from 10 assays 
of the same sample (in duplicates) was 0.87% and 
the inter-assay variation calculated from 10 runs 
on duplicate samples was 1.47%. The intra- and in-
ter-assay variations were performed using quality 
control material at level 1.
Statistical analysis
Statistical analysis was performed using Statistica 
12.0 PL (StatSoft Inc. 2014, Oklahoma, USA) and 
MedCalc 16.2.1 (MedCalc Software 2016, Ostend, 
Belgium) for Windows. The normality of distribu-
tion was evaluated by Shapiro-Wilks test. All varia-
bles had non-Gaussian distribution and were com-
pared using Wilcoxon matched pairs test (compar-
ison between two groups) and ANOVA Kruskal-
Wallis test (comparison of more than two groups). 
The concordance of HbA1c values was assessed by 
Bland-Altman plot. P < 0.05 was considered signifi-
cant.
To evaluate the significance of changes in HbA1c 
concentrations after sample freezing, the repeata-
bility was calculated. Repeatability was considered 
as absolute difference between HbA1c concentra-
tion measured in fresh blood samples and in fro-
zen/thawed samples. A difference of 5 mmol/mol 
(0.5%) in HbA1c concentration between samples 
was considered clinically significant. 
Bias between HbA1c in fresh and frozen samples 
was calculated using the following formula: Bias 
(%) = [(HbA1c fresh - HbA1c frozen) / HbA1c fresh] x 
100%. According to the recent findings from 
“Guideline-Driven Medical Decision Limits” bias 
less than 1.0% is recommended to obtain clinically 
useful HbA1c results (10).
Results
Median of HbA1c concentration was 45.3 (36.6 - 
61.2) mmol/mol (6.3 (5.5–7.8)%) for all fresh sam-
ples and 45.3 (36.6–60.6) mmol/mol (6.3 (5.5–
7.7)%) for frozen/thawed samples (P = 0.070). In 
healthy subjects median of HbA1c concentration 
was 37.2 (34.4–43.1) mmol/mol for fresh and 36.9 
(34.4–43.1) mmol/mol for frozen/thawed samples (P 
= 0.062). Similarly, no significant differences were 
observed in patients with diabetes (P = 0.086). 
Repeatability of HbA1c concentration after single 
freeze/thaw cycle is presented in Figure 1. No 
changes in HbA1c concentration was found in 
48.4% of subjects (N = 62), while in 41.4% cases (N 
= 53) the obtained results were lower (mean 1.4 
mmol/mol) and in 10.1% cases (N = 13) the results 
were higher (mean 2.3 mmol/mol) than baseline 
HbA1c values, respectively. However, the observed 
differences in HbA1c concentrations between fresh 
and frozen/thawed samples were not statistically 
significant (P = 0.110).
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Samples were divided according to storage time: 
2–5, 6–9 and 10–12 weeks, respectively (Table 1). 
No significant differences in HbA1c concentration 
were found comparing frozen/thawed samples 
stored in different time intervals when compared 
to fresh blood samples. 
Samples were divided according to baseline HbA1c 
values into three groups: < 39 mmol/mol (< 5.7%), 
39 - 47 mmol/mol (5.7–6.4%) and ≥ 48 mmol/mol 
(≥ 6.5%). No significant differences were observed 
between HbA1c concentration in fresh and frozen/
thawed samples in each group (Table 2).
The Bland-Altman plot analysis (Figure 2) showed 
a positive bias of 0.4% (95% CI: -2.8–3.7%), which 
indicates high compliance between HbA1c values 
measured in fresh and frozen/thawed samples.
Storage time, weeks
HbA1c concentration, mmol/mol
Fresh samples Frozen/thawed samples P
2–5 weeks
(N = 40) 36.1 (34.4–58.5) 36.0 (34.4–58.5) 0.270
6–9 weeks 
(N = 45) 45.3 (38.8–61.7) 46.4 (37.7–48.4) 0.390
10–12 weeks
(N = 43) 45.3 (36.6–55.2) 45.3 (36.1–54.1) 0.130
Results are presented as median and interquartile range (IQR). Difference in HbA1c concentrations between fresh 
and frozen/thawed samples were teste using the Wilcoxon test. P<0.05 was considered statistically significant.
Table 1. Effect of storage time on HbA1c concentration in frozen/thawed samples 
Figure 1. Repeatability of HbA1c concentrations after single 
freeze/thaw cycle. A difference of 5 mmol/mol (0.5%) in HbA1c 
concentration between samples was considered as significant 
change.
Baseline HbA1c concentration, 
mmol/mol
HbA1c concentration, mmol/mol
Fresh samples Frozen/thawed samples P
< 39
(N = 32) 34.4 (33.3–36.6) 34.4 (32.2–36.6) 0.150
39 - 47 
(N = 38) 45.3 (42.1–46.4) 44.2 (42.1–46.4) 0.650
≥ 48 
(N = 58) 66.1 (55.2–79.2) 67.2 (55.2–79.2) 0.250
Results are presented as median and interquartile range (IQR). Difference in HbA1c concentrations between fresh 
and frozen/thawed samples were teste using the Wilcoxon test. P<0.05 was considered statistically significant.
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The median calculated bias between fresh and fro-
zen samples was 0% in whole group and in healthy 
subjects (interquartile range (IQR): 0–1.64%) and 
1.19% (IQR: 0–2.15%) in diabetic patients, respec-
tively. No significant difference was found be-
tween the biases according to the baseline HbA1c 
values (P = 0.150; Figure 3).
Discussion
We demonstrated good stability of HbA1c meas-
ured in whole blood samples stored for 2–12 
weeks at –80 °C. Comparison of HbA1c concentra-
tion in fresh and frozen/thawed samples indicates 
high compliance, independently of storage time 
and baseline HbA1c concentrations.
A study performed in France showed that HbA1c 
concentration assayed by ion-exchange HPLC 
method (Bio-Rad Variant II®; Bio-Rad Laboratories, 
CA, USA) is stable at –80 °C for at least one year 
and for 2 weeks when stored at 4 °C (9). However, 
substantial HbA1c degradation occurred at –20 °C 
after 15 days of storage; therefore, this tempera-
ture is not recommended for HbA1c sample stor-
age. Similar results were observed in a study by 
Little et al. They found that HbA1c measured on five 
different HPLC autoanalyzers was the most stable 
at –70 °C (for a storage period of 57 days), while in 
four methods stability at 4 °C was higher than at – 
20 °C (14–57 vs. 3 - 28 days, respectively) (11). Al-
though HbA1c stability was analysed in different 
temperature and storage time periods, the rele-
vance of the results appears to be significantly lim-
ited due to very low number of samples (only 
three samples in each study).
Storage at very low temperature (–70 °C or lower) 
might be useful also in case of quality control ma-
terials. Marron et al. compared imprecision of 
Lyphocheck® Diabetes Control Bilevel (Bio-Rad 
Laboratories, CA, USA) measured on HPLC instru-
ment (12). Control material was stored up to 7 days 
in 2–8 °C and alternatively frozen in 10 µL aliquots 
at –80 °C. The coefficient of variation (CV) ob-
tained by standard procedure were 2.33% and 
2.51% for level 1 and 2, respectively; while the CV 
obtained by alternative procedure were signifi-
cantly lower: 1.93% (P < 0.001) and 0.99% (P = 
0.003). Moreover, control materials freezing re-
duced costs of quality control by 80%. Optimiza-
tion of quality control and cost saving may be im-
portant especially in small-scale laboratories, 
where HbA1c measurements are not performed 
every day.
Although freezing seems to be an effective way to 
store blood samples for HPLC methods, some au-
Figure 2. Bland-Altman plot of differences in HbA1c concentra-
tions in fresh and frozen/thawed samples. Solid line (Mean) – 
mean difference. Grey lines – 95% confidence intervals of mean 
difference. Dashed lines (SD) – standard deviation.
Figure 3. Comparison of bias values according to baseline 
HbA1c concentration (ANOVA Kruskal-Wallis test). Q1 – first 
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thors consider that long-term storage may in-
crease HbA1c concentration assayed by mass spec-
trometry methods. D’Alessandro et al. observed 
relative percentage increase in HbA1c concentra-
tion in samples frozen for 28–42 days compared 
with samples stored up to 14 days, however the 
authors did not clearly state the freezing tempera-
ture (13). This effect was explained by use of addi-
tive solutions, such as SAGM (saline-adenine-glu-
cose-mannitol) for blood banking which results in 
prolonged exposure of erythrocytes to high glu-
cose concentrations. However, their study group 
consisted of only 10 healthy volunteers, thus the 
results should be interpreted with caution. The in-
fluence of SAGM on HbA1c concentrations should 
be verified in samples obtained from patients with 
diabetes or elderly subjects, who have increased 
rate of glycation.
Recent studies suggest that repeatability of HbA1c 
measurements depends on baseline HbA1c con-
centration in fresh blood samples. In a study by Li-
otta et al., including 237 subjects with type 2 dia-
betes, HbA1c levels measured by ion-exchange 
HPLC method were compared in fresh samples 
and samples stored for 1 year at –80 °C (14). HbA1c 
concentrations were significantly decreased after 
freezing and refreezing in patients with lower (< 
6.5%), increased (6.5–8.0%) and very high (> 8.0%) 
baseline concentrations. Moreover, bias was signif-
icantly higher in subjects with HbA1c ≥ 6.5% com-
pared with those with HbA1c < 6.5%, and increas-
ing bias values were observed in subsequent con-
centration intervals of baseline HbA1c. However, 
our results did not confirm this tendency in both 
diabetic and healthy subjects.
In the Atherosclerosis Risk in Communities (ARIC) 
study HbA1c concentration in 14 069 whole blood 
samples was measured by HPLC method after 
storage for 14 and 18 years at –70 °C. The correla-
tion between measurements at the two time 
points was high; however a slight positive bias of 
0.29% was found when comparing samples stored 
for 18 years to those stored for 14 years (15).
For HbA1c measurement used in particular as a di-
agnostic tool for diabetes diagnosis, evaluation of 
diabetes risk in general population or establishing 
therapeutic goals in diabetic patients the corre-
sponding values of analytical quality indicators 
must be maintained. According to generally ac-
cepted rule in clinical practice, difference of 5 
mmol/mol (0.5%) in HbA1c concentration between 
patients samples is considered as a significant 
change in glycemic control (16, 17). When compar-
ing this criterion with the repeatability observed in 
our study, it can be concluded that single freeze/
thaw cycle does not affect the clinical significance 
of HbA1c measurement. However, the evaluation of 
clinical significance of HbA1c concentrations should 
also consider the analytical bias of assay used. A 
recent study by Hyltoft Petersen and Klee, which 
appraises the influence of analytical bias and im-
precision on the number of false positive results, 
recommends bias less than 1.0% to obtain clinical-
ly useful HbA1c results (10). In our study a slight 
positive bias of 0.4% between HbA1c values in fresh 
and frozen/thawed samples was found in Bland-
Altman plot analysis. Thus, high compliance of re-
sults obtained in both diabetic and healthy indi-
viduals was demonstrated, with no significant ef-
fect on HbA1c measured from samples stored at - 
80 °C. Several studies indicate different bias of 
HbA1c concentration assayed by comparable 
methods. For example, study performed in Den-
mark proposed a more restrictive bias (i.e. less 
than 0.3%), which provides acceptable accuracy 
for the detection of significant changes in glyce-
mic control and risk prediction of diabetic compli-
cations (18).
Despite potentially interesting findings, we should 
emphasize the important limitations of this study. 
First, study consisted of relatively small number of 
subjects and storage time was relatively short, 
therefore results require confirmation in extended 
population-based study. Moreover, the time be-
tween blood collection, HbA1c assay and samples 
freezing should be unified. Almost all samples 
were delivered to the laboratory, measured and 
frozen immediately after collection; however, sev-
eral of them were stored at 4 °C and assayed not 
later than within 24 hours, which may possibly in-
duce some variation in HbA1c concentration. How-
ever, it is worth emphasizing that our study includ-
ed significantly greater number of analyzed sam-
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ples, when compared to previously published re-
search. Moreover, it is one of the few studies which 
evaluated the stability of HbA1c concentration dur-
ing freezing in both healthy and diabetic subjects. 
Obtained results indicate that sample storage at – 
80 °C does not affect the clinical significance of 
HbA1c measurement on HPLC autoanalyzer, there-
fore this method of storage might be crucial for 
maintaining analytical quality of assay, as well as 
for its cost-effectiveness.
In conclusion, whole blood samples storage at - 80 
°C up to 12 weeks and a single freeze/thaw cycle 
do not affect the concentration of HbA1c measured 
by HPLC method on Bio-Rad D-10® analyzer in 
healthy and diabetic subjects. However, due to rel-
atively short storage period studied, results should 
be confirmed by measuring HbA1c levels in long-
term stored samples.
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